Literature DB >> 14684991

Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer.

Y-F C Lau1, H W Lau, L G Kömüves.   

Abstract

The contribution of specific genes on the Y chromosome in the etiology of prostate cancer has been undefined. Genetic mapping studies have identified a gonadoblastoma locus on the human Y chromosome (GBY) that predisposes the dysgenetic gonads of XY sex-reversed patients to tumorigenesis. Recently a candidate gene, the testis-specific protein Y-encoded (TSPY) that resides on the GBY critical region, has been demonstrated to express preferentially in tumor cells in gonadoblastoma and testicular germ cell tumors. TSPY shares high homology to a family of cyclin B binding proteins and has been considered to possibly play a role in cell cycle regulation or cell division. To address the possible involvement of the TSPY gene in prostate cancer, both in situ mRNA hybridization and immunohistochemistry techniques were used to study the expression of this putative GBY gene in prostate specimens. Our results demonstrated that TSPY was expressed at low levels in normal epithelial cells and benign prostatic hyperplasia (BPH), but at elevated levels in tumor cells of prostate cancers at various degrees of malignancy. Sequence analysis of RT-PCR products obtained from both prostatic and testicular tissues using specific primers flanking the open reading frame of the TSPY mRNA revealed a complex pattern of RNA processing of the TSPY transcripts involving cryptic intron splicing and/or intron skipping. The variant transcripts encode a variety of polymorphic isoforms or shortened versions of the TSPY protein, some of which might possess different biochemical and/or functional properties. The abbreviated transcripts were more abundant in prostatic cancer tissues than the testicular ones. Although the exact nature of such variant TSPY transcripts and proteins is still unclear, their differential expression suggests that the TSPY gene may also be involved in the multi-step prostatic oncogenesis besides its putative role in gonadoblastoma and testicular seminoma. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14684991     DOI: 10.1159/000074345

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  17 in total

1.  Survey of differentially methylated promoters in prostate cancer cell lines.

Authors:  Yipeng Wang; Qiuju Yu; Ann H Cho; Gaelle Rondeau; John Welsh; Eileen Adamson; Dan Mercola; Michael McClelland
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

2.  The Y-located proto-oncogene TSPY exacerbates and its X-homologue TSPX inhibits transactivation functions of androgen receptor and its constitutively active variants.

Authors:  Yunmin Li; Dong Ji Zhang; Yun Qiu; Tatsuo Kido; Yun-Fai Chris Lau
Journal:  Hum Mol Genet       Date:  2017-03-01       Impact factor: 6.150

3.  Human Y-chromosome variation and male dysfunction.

Authors:  Cláudia Márcia Benedetto de Carvalho; Fabrício Rodrigues Santos
Journal:  J Mol Genet Med       Date:  2005-12-06

4.  The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors.

Authors:  Yunmin Li; Z Laura Tabatabai; Tin-Lap Lee; Shingo Hatakeyama; Chikara Ohyama; Wai-Yee Chan; Leendert H J Looijenga; Yun-Fai Chris Lau
Journal:  Hum Pathol       Date:  2007-05-22       Impact factor: 3.466

5.  TSPYL2 is important for G1 checkpoint maintenance upon DNA damage.

Authors:  Kin Pong Tao; Sze Wan Fong; Zhihong Lu; Yick Pang Ching; Kin Wang Chan; Siu Yuen Chan
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

6.  The X-linked tumor suppressor TSPX interacts and promotes degradation of the hepatitis B viral protein HBx via the proteasome pathway.

Authors:  Tatsuo Kido; Jing-Hsiung James Ou; Yun-Fai Chris Lau
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

7.  Upregulation of the cell-cycle regulator RGC-32 in Epstein-Barr virus-immortalized cells.

Authors:  Sandra N Schlick; C David Wood; Andrea Gunnell; Helen M Webb; Sarika Khasnis; Aloys Schepers; Michelle J West
Journal:  PLoS One       Date:  2011-12-06       Impact factor: 3.240

8.  TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells.

Authors:  Shane W Oram; Xing Xing Liu; Tin-Lap Lee; Wai-Yee Chan; Yun-Fai Chris Lau
Journal:  BMC Cancer       Date:  2006-06-09       Impact factor: 4.430

Review 9.  Roles of the Y chromosome genes in human cancers.

Authors:  Tatsuo Kido; Yun-Fai Chris Lau
Journal:  Asian J Androl       Date:  2015 May-Jun       Impact factor: 3.285

10.  TSPY1 copy number variation influences spermatogenesis and shows differences among Y lineages.

Authors:  Claudia Giachini; Francesca Nuti; Daniel J Turner; Ilaria Laface; Yali Xue; Fabrice Daguin; Gianni Forti; Chris Tyler-Smith; Csilla Krausz
Journal:  J Clin Endocrinol Metab       Date:  2009-09-22       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.